TETI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 6.012
EU - Europa 5.332
AS - Asia 2.388
SA - Sud America 775
AF - Africa 45
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.567
Nazione #
US - Stati Uniti d'America 5.960
IE - Irlanda 1.411
CN - Cina 1.264
SE - Svezia 1.238
SG - Singapore 885
BR - Brasile 695
IT - Italia 630
UA - Ucraina 542
DE - Germania 510
FI - Finlandia 282
PL - Polonia 193
GB - Regno Unito 164
FR - Francia 135
RU - Federazione Russa 54
BE - Belgio 48
CZ - Repubblica Ceca 48
IN - India 39
VN - Vietnam 26
AR - Argentina 25
HK - Hong Kong 22
CA - Canada 19
UZ - Uzbekistan 19
BD - Bangladesh 15
MA - Marocco 15
MX - Messico 15
AT - Austria 14
IQ - Iraq 13
NL - Olanda 13
CO - Colombia 12
ZA - Sudafrica 12
EC - Ecuador 11
PK - Pakistan 11
CL - Cile 10
TR - Turchia 10
ID - Indonesia 9
JO - Giordania 9
IR - Iran 8
DO - Repubblica Dominicana 7
PE - Perù 7
RO - Romania 7
TN - Tunisia 7
BG - Bulgaria 6
EU - Europa 6
LV - Lettonia 6
NP - Nepal 6
PS - Palestinian Territory 6
VE - Venezuela 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
AU - Australia 4
CH - Svizzera 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AL - Albania 3
BO - Bolivia 3
CR - Costa Rica 3
HR - Croazia 3
IL - Israele 3
NO - Norvegia 3
UY - Uruguay 3
AO - Angola 2
BN - Brunei Darussalam 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
ES - Italia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
JP - Giappone 2
LK - Sri Lanka 2
PA - Panama 2
PH - Filippine 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
NG - Nigeria 1
SA - Arabia Saudita 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.567
Città #
Dublin 1.411
Chandler 1.128
Jacksonville 1.120
Nyköping 687
Singapore 515
Shenzhen 448
Beijing 350
Messina 287
Ashburn 278
Dearborn 249
Princeton 243
Cambridge 235
Medford 235
Boardman 213
Des Moines 195
Warsaw 192
Ann Arbor 188
Woodbridge 80
Bremen 70
New York 64
Los Angeles 63
Shenyang 57
Wilmington 57
Jinan 54
São Paulo 49
Brussels 48
San Mateo 47
Brno 46
Helsinki 43
Nanjing 33
Pune 31
Lancaster 30
Haikou 29
Hebei 26
Munich 26
Ningbo 25
Nuremberg 25
Tianjin 25
Belo Horizonte 23
Dong Ket 23
Hong Kong 22
Norwalk 22
Seattle 22
Zhengzhou 22
Milan 21
Rio de Janeiro 18
Rome 18
Taiyuan 18
Tashkent 18
The Dalles 17
Houston 16
Taizhou 16
Hangzhou 15
Guangzhou 14
Brasília 13
Catania 13
Washington 13
Nanchang 11
Clearwater 10
Fuzhou 10
Auburn Hills 9
Changsha 9
Ottawa 9
São José dos Campos 9
Amman 8
Clifton 8
Guarulhos 8
Jiaxing 8
Leawood 8
Siracusa 8
Ardabil 7
Augusta 7
Campinas 7
Canoas 7
Hefei 7
Lanzhou 7
Lima 7
Napoli 7
Pavia 7
Ribeirão Preto 7
Saint Petersburg 7
Vienna 7
Bogotá 6
Falls Church 6
Goiânia 6
Guayaquil 6
Jakarta 6
Kemerovo 6
Modica 6
Porto Alegre 6
Riva 6
Tappahannock 6
Amsterdam 5
Baghdad 5
Baku 5
Carapicuíba 5
Caxias do Sul 5
Curitiba 5
Johannesburg 5
Lappeenranta 5
Totale 9.545
Nome #
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. 520
ATTIVAZIONE DI NLRP3 IMFLAMMASOMA NEL CORSO DELLE INFEZIONI SOSTENUTE DAGLI STREPTOCOCCHI DI GRUPPO B 157
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. 143
Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology 133
Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform 129
The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci 128
beta(2) integrins are involved in cytokine responses to whole Gram-positive bacteria 102
Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant 96
The dual role of innate immunity during influenza 95
Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor 94
Caratterizzazione molecolare di glicoproteine criptococciche capaci di indurre risposte umorali. 93
Approccio proteomico per l’analisi comparativa del secretoma di coltura di S. agalactiae, ceppo Nem316 92
“Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor” 91
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. 91
Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries 90
A new surface protein of Streptococcus suis identified by proteomics 88
La proteina FbsA di Streptococcus agalactiae è unimportante fattore di virulenza 87
The Phagocyte, Metchnikoff, and the Foundation of Immunology 87
VACCINE FORMULATIONS COMPRISING ANTIIDIOTYPIC ANTIBODIES WHICH IMMUNOLOGICALLY MIMIC GROUP B STREPTOCOCCAL CARBOHYDRATES 86
Attivazione dell'inflammasoma da parte di S.pneumoniae 86
Protective activity of a protein fragment identified by the screening of a Streptococcus pneumoniae phage-displayed genomic library 86
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection 85
CXCL1/2 chemokines are newly synthesized by neutrophils and released at high levels after recognition of live Group B Streptococcus by means of endosomal Toll-like receptors 85
Anti-idiotypic B5 single chain variable fragment [synthetic construct]. 84
Costruzione e screening di librerie “lambda display” da genoma completo di streptococchi patogeni per l’identificazione di prodotti genici che interagiscono con i tessuti dell’ospite. 84
Analysis of the secretome of the group B Streptococcus 84
Bacteroides fragilis lipopolysaccharide activates cells via CD14/MD2/TLR4 83
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes 81
Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade 81
CELL ACTIVATION INDUCED BY LIPOTEICHOIC ACID AND POLYSACCHARAIDES FRM STREPTOCOCCI. 80
MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans 80
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection 80
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci 79
Anti-idiotypic G1 single chain variable fragment [synthetic construct]. 78
NEUTROPHILS PRODUCE HIGH LEVELS OF CHEMOKINES (CXCL1/2) AFTER SENSING GROUP B STREPTOCOCCUS THROUGH ENDOSOMAL TLRS 78
PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of Group B Streptococcus 78
AGE-RELATED MORTALITY AND ADHERENT SPLENIC CELL MEDIATOR PRODUCTION TO ENDOTOXIN IN THE RAT 77
Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization 77
Immunogenic mimics of Brucella lipopolysaccharide epitopes 77
Immunoprotective activity of a Streptococcus pneumoniae protein identified by phage display. 77
Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library. 77
Risposta dell'Ospite alle Infezioni Batteriche 76
Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease 76
Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans 76
Essential role of interleukin-1 signaling in host defenses against group B streptococcus 76
The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/αvintegrin axis 76
Identificazione mediante “Phage Display” diframmenti biologicamente attivi della fibrinogenbinding protein A (FbsA) di Streptococcus agalactiae. 75
Anti-idiotypic vaccination against group B streptococci 74
IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type I pattern during experimental cryptococcosis 72
Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen- Specific Libraries 72
Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs 72
Ruolo dell'interluchina 18 nelle infezioni da streptococco di gruppo B. 71
Analysis of the Streptococcus agalactiae exoproteome. 71
Immunità protettiva indotta da una glutamina sintetasi di Cryptococcus neoformans 70
Vaccinazione anti-idiotipica a DNA per l'induzione di anticorpi diretti contro il polissacaride di batteri capsulati. 70
BETA-LACTAM ANTIBIOTICS (AZTREONAM, AMPICILLIN, CEFAZOLIN AND CEFTAZIDIME) IN THE CONTROL AND ERADICATION OF SALMONELLA- TYPHIMURIUM IN NATURALLY RESISTANT AND SUSCEPTIBLE MICE 70
A meeting of mimics. 70
Neutrophils Enhance Their Own Influx to Sites of Bacterial Infection via Endosomal TLR-Dependent Cxcl2 Production 70
Vaccinazione anti-idiotipica nei confronti di infezioni sperimsntali da Neisseria meningitidis di gruppo B con anticorpi ricombinanti immagini interne del polissacaride capsulare. 69
Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4 69
G(i) proteins regulate lipopolysaccharide and Staphylococcus aureus induced cytokine production but not (1 -> 3)-beta-D-glucan induced cytokine suppression 69
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 69
DETECTION OF GROUP-B STREPTOCOCCI BY DIRECT NITROUS-ACID EXTRACTION OF VAGINAL SPECIMENS AND LATEX AGGLUTINATION 69
Characterization of two novel Cryptococcal mannoproteins recognized by immune sera 69
Plasminogen- and Fibronectin–Binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells. 69
The IL-1b/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection 69
L'IFN-beta è fondamentale nel polarizzare la risposta citochinica verso il tipo 1 nel corso dell'infezione da cryptococcus neoformans. 68
Therapy of mucosal candidiasis by expression of an anti- idiotype in human commensal bacteria 68
ANTI-LIPOTEICHOIC ACID ANTIBODIES ENHANCE RELEASE OF CYTOKINES BY MONOCYTES SENSITIZED WITH LIPOTEICHOIC ACID 68
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 68
Uso del “phage display”per caratterizzare ilrepertorio anticorpale indotto da vaccinazione. 68
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components 67
Activation of the NLRP3 inflammasome by group B streptococci. 67
Role of the TLR2/MYD88 activation pathway in group B streptococcal infections. 66
Immunoprotective cryptococcal proteins 66
New orientations in chemotherapy for gastric carcinoma 66
Virus ed infezioni alimentari: il caso dell’epatite A 66
Selection of Neisseria meningitidis group B antigenic epitopes using lambda libraries. 66
Sherris Microbiologia Medica 66
The Mannoprotein Cig1 supports iron acquisition from heme and virulence in the pathogenic fungus Cryptococcus neoformans. 66
Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock 65
Identification and cloning of a cryptococcal deacetylase that produces protective immune responses 65
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease 65
Effects of anti-cytokine treatments in neonatal sepsis models 64
Tumor necrosis factor-inducing activities of Cryptococcus neoformans components (vol 64, pg 5199, 1996) 64
Identification of major proteins secreted by Cryptococcus neoformans 64
Compositional analysis of the major capsular polysaccharides of Cryptococcus neoformans by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) 64
Cross reattività di una lipoproteina di Neisseriameningitidis con la proteina legante il fattore H (fHbp) 64
Recognition of yeast nucleic acids triggers a host-protective type I interferon response 64
PEPTIDES THAT MIMIC NON-HUMAN CROSS-REACTIVE PROTECTIVE EPITOPES OF THE GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE 63
Brucellosi:Aspetti medici e sociali 63
Age-related sensitivity of neonatal mice to toxicity induced by heat-killed group B streptococci. 63
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice 63
Proceedings of the second Centro 3R Annual Meeting | September 30th - October 1st of Biomedical Science and Engineering. Vol. 4 No. s1 (2021) 63
CYTOKINE APPEARANCE AND EFFECTS OF ANTITUMOR NECROSIS FACTOR- ALPHA ANTIBODIES IN A NEONATAL RAT MODEL OF GROUP-B STREPTOCOCCAL INFECTION 62
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria 62
Studio delle vie di trasduzione del segnale coinvolte nell’induzione di IFN b da parte delle cDC infettate in vitro con Aspergillus fumigatus 62
BENEFICIAL-EFFECTS OF INTERLEUKIN-6 IN NEONATAL MOUSE MODELS OF GROUP-B STREPTOCOCCAL DISEASE 61
Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. 60
Identification Of Microbial Proteins Involved In Interaction With ECM Proteins By Using Lambda-Display Libraries 60
Totale 8.165
Categoria #
all - tutte 57.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020630 0 0 0 0 0 0 0 0 35 232 342 21
2020/20211.683 186 23 349 91 116 219 45 146 79 199 139 91
2021/20221.600 18 259 16 34 37 11 114 76 17 192 288 538
2022/20234.266 341 348 178 388 412 408 58 243 1.712 19 115 44
2023/20241.456 86 159 526 86 105 212 7 58 2 33 16 166
2024/20252.341 79 53 81 289 140 161 89 1.123 326 0 0 0
Totale 14.747